Revanesse Versa Hyaluronic Acid Dermal Fillers: Advanced Spherical Gel Technology

Structural mid-face aging and facial volume depletion occur through progressive collagen breakdown, fat pad atrophy, and natural hyaluronic acid degradation in the extracellular matrix. Traditional cross-linked dermal fillers often contain non-uniform particle sizes, which can lead to uneven swelling and tissue distortion. Revanesse Versa—developed by Prollenium Medical Technologies—is a premium hyaluronic acid dermal filler formulated through a proprietary wet-milling process. This specialized manufacturing technique yields perfectly spherical, uniform HA particles that gel smoothly and integrate seamlessly into the mid-to-deep dermis. Licensed aesthetic practices rely on Pro Filler Supply for verified authentic Revanesse products preserved under strict storage standards.

Revanesse Versa delivers a distinct volumetric advantage: each syringe contains 1.2mL of product—offering 20% more filler volume than the standard 1.0mL syringes offered by competitors. Engineered with high molecular weight HA (25 mg/mL) and optimized BDDE cross-linking, Versa balances ideal rheological lifting capacity with high biocompatibility.

Product Formulations & Technical Specifications

Selecting the ideal Revanesse formulation depends on the anatomical treatment area, dermal depth, and tissue dynamic demands:

Standard Gel Formulation

Pure, bioresorbable cross-linked HA formulated without lidocaine for patients with anesthetic sensitivities or specific clinical protocols.

Versa+ Integrated Lidocaine Option

The core 1.2mL high-yield formulation integrated with 0.3% lidocaine hydrochloride to optimize patient comfort during mid-to-deep dermal placement.

Targeted Submucosal Micro-Gel

A targeted micro-gel formulation optimized for submucosal implantation, offering soft, natural lip augmentation and perioral rhytid correction.

Clinical research archived on the NCBI Bookshelf confirms that uniform spherical HA particles reduce localized physical inflammatory stress, significantly lowering post-procedure edema while promoting tissue integration.

Quality Protocol & Storage Assurance

Maintaining cross-linked gel integrity and syringe sterility requires rigid handling and storage standards:

Cold-Chain Management & Traceability

• Storage Stability: Revanesse Versa syringes are stored in controlled conditions (2°C to 25°C) to maintain cross-linked bond stability and gel rheology.

• Traceability Assurance: Every syringe box features verifiable factory lot numbers, serial numbers, tamper-evident seals, and detachment labels for patient medical records.

Clinical Administration Best Practices

• Perform mid-to-deep dermal injections using 27G or 30G fine-gauge needles or blunt-tip micro-cannulas.

• Maintain precise linear threading, serial puncture, or cross-hatching techniques to achieve smooth structural correction.

To review complete product specifications, explore the Pro Filler Supply Shop or check our FAQ Page.

Safety advisories published by the U.S. Food and Drug Administration emphasize that medical devices and cross-linked dermal fillers must be sourced exclusively through verified vendors to guarantee product safety.

Practice Fulfillment & Ordering Options

Pro Filler Supply is committed to supporting licensed aesthetic practitioners with authentic, high-performance dermal fillers. Our temperature-monitored distribution channels ensure your clinic inventory arrives intact, sterile, and fully compliant.

• Authentic Prollenium inventory with intact manufacturer seals and lot tracking

• High-yield 1.2mL syringe packaging offering exceptional practice value

• Streamlined online ordering for efficient inventory management

• Fast, reliable shipping options to avoid treatment delays

To establish a clinic account, connect with us through the Contact Us Page. Learn more about our distribution standards on our About Us Page.